Professional profile
Antonio Craxì is a clinician and researcher in hepatology and gastroenterology, and a former Full Professor at the University of Palermo. His research encompasses viral hepatitis, antiviral treatment and resistance, cirrhosis and hepatocellular carcinoma. Since retiring from his university and hospital appointments on 31 October 2022, he has continued to work as a senior clinical consultant and to contribute to research, foundations and scientific networks. He is President and Legal Representative of Fondazione VIRONET ETS.
Areas of expertise
HCV: Natural history, antiviral therapy, resistance, outcomes after viral clearance, screening, linkage to care and elimination.
HBV and HDV: Clinical virology, antiviral treatment, occult HBV infection, reactivation, diagnostic testing and prevention.
Liver cancer and other liver diseases: Hepatocellular carcinoma, metabolic dysfunction-associated steatotic liver disease, autoimmune liver disease and portal hypertension; research on COVID-19 and liver care.
Professional profile
Antonio Craxì is a clinician and researcher in hepatology and gastroenterology, and a former Full Professor at the University of Palermo. His research encompasses viral hepatitis, antiviral treatment and resistance, cirrhosis and hepatocellular carcinoma. Since retiring from his university and hospital appointments on 31 October 2022, he has continued to work as a senior clinical consultant and to contribute to research, foundations and scientific networks. He is President and Legal Representative of Fondazione VIRONET ETS.
Areas of expertise
HCV: Natural history, antiviral therapy, resistance, outcomes after viral clearance, screening, linkage to care and elimination.
HBV and HDV: Clinical virology, antiviral treatment, occult HBV infection, reactivation, diagnostic testing and prevention.
Liver cancer and other liver diseases: Hepatocellular carcinoma, metabolic dysfunction-associated steatotic liver disease, autoimmune liver disease and portal hypertension; research on COVID-19 and liver care.